Prognotic Role of CMR in Takotsubo Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognotic Role of CMR in Takotsubo Syndrome — Stella

Recruiting

Back to Takotsubo Cardiomyopathy trials

Trial locations(1 site)

Italy

University of Cagliari, Cagliari, Italy

Key details

Sponsor

University of Cagliari

Collaborators

Centro Cardiologico Monzino, IRCCS San Raffaele

Enrollment target

~350 participants

Started

November 2022

Primary completion

November 2026

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov